학술논문 – 법학도서관

학술논문

replay검색결과 돌아가기

search검색화면

First-in-human, multicenter, dose-escalation, phase I study of the investigational drug TAK-733, an oral MEK inhibitor, in patients (pts) with advanced nonhematologic malignancies and melanoma.

Document Type

Journal

Author

Sosman, J. A.; Adjei, A. A.; LoRusso, P.; Michael, S. A.; Dy, G. K.; Bowditch, A.; Chmielowski, B.; Lee, S.; Walker, R. M.; Faucette, S.; Izmailova, E. S.; Bozon, V.; Ribas, A.

Source

JOURNAL OF CLINICAL ONCOLOGY; MAY 20 2011, 29 15, 1p. Supplement: S

Subject

Language

English

ISSN

15277755

Online Access

Web of Science JCR 저널정보 Find it@PNU

이메일